Summary
A case study describing PRA's involvement in an accelerated schedule vaccine study for poliomyelitis.
Register to download
Early Engagement Crucial to Develop Trial Design for Accelerated Schedule Vaccine Study
You may also be interested in:
Case Study
PRA’s Unique Model Leads to Client Satisfaction
A randomized, multi-center, double-blind study to compare the efficacy and safety of Study Drug A and Study Drug B as monotherapy in newly diagnosed…
View Resource
Fact Sheet
Vaccine Solutions
PRA’s Vaccine Solutions group understands the unique challenges and characteristics of vaccine development. Right from the start, our experts will…
View Resource
resource
The Future of Clinical Trials: Connected and Virtual Approaches for Rare Diseases
Scott Schliebner, Senior Vice President, Center for Rare Diseases at PRA Health Sciences talks about how amore patient-centred approach is needed to…
View Resource
View all related content and resources for Study Design
Explore Insights